首页> 中文期刊> 《中国癌症研究:英文版》 >Update in version 2021 of CSCO guidelines for colorectal cancer from version 2020

Update in version 2021 of CSCO guidelines for colorectal cancer from version 2020

         

摘要

Colorectal cancer(CRC) is one of the major cancers threatening life and health of Chinese residents. According to the latest data released by the National Cancer Center in2015(1), there were 387,000 new cases and 187,100 deaths of CRC in China, accounting for 9.87% and 8.01% of all malignancies. The first version of the Chinese Society of Clinical Oncology(CSCO) guidelines was released in April2017, and has been updated annually based on the latest clinical research data and the availability of new drugs(2-4). Here, we present the main updates of the 2021 version compared to 2020 version.

著录项

  • 来源
    《中国癌症研究:英文版》 |2021年第3期|302-307|共6页
  • 作者单位

    Department of Medical Oncology;

    The Second Affiliated Hospital of Zhejiang University School of Medicine;

    Hangzhou 310009;

    China;

    Cancer Center;

    Zhejiang University;

    Hangzhou 310058;

    China;

    Cancer Institute;

    Key Laboratory of Cancer Prevention and Intervention;

    Ministry of Education;

    The Second Affiliated Hospital of Zhejiang University School of Medicine;

    Hangzhou 310009;

    China;

    Department of Radiation Oncology;

    Fudan University Shanghai Cancer Hospital;

    Shanghai 200032;

    China;

    Department of Colorectal Surgery;

    The Second Affiliated Hospital of Zhejiang University School of Medicine;

    Hangzhou 310009;

    China;

  • 原文格式 PDF
  • 正文语种 chi
  • 中图分类 肿瘤学;
  • 关键词

    CSCO; cancer; drugs;

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号